SCHEMBL16675416

SCHEMBL16675416

O=C1OCC(COCCCCOCC2COC(=O)O2)O1

nearest known ligand 0.52

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
ALDH1A1 P00352 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 2/20 0.32
MAPK1 P28482 1/20 0.32
S1PR1 P21453 2/20 0.30
SGPL1 O95470 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22193341 0.98 TSHR (0.50) TSHRALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL14003900 0.98 TSHR (0.50) TSHRALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL16663913 0.96 TSHR (0.47) TSHRALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL6553153 0.92 TSHR (0.40) TSHRALDH1A1TDP1SMN1; SMN2
SCHEMBL24520577 0.92 ALDH1A1 (0.57) TSHRALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL22735058 0.91 TSHR (0.42) TSHRALDH1A1TDP1SMN1; SMN2MAPK1
SCHEMBL17461572 0.90 TSHR (0.39) TSHRALDH1A1TDP1SMN1; SMN2
SCHEMBL17108347 0.90 ALDH1A1 (0.60) TSHRALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL14895171 0.90 ALDH1A1 (0.60) TSHRALDH1A1TDP1SMN1; SMN2LMNA
SCHEMBL8056682 0.90 ALDH1A1 (0.60) TSHRALDH1A1TDP1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240301266-A1 POLY(HYDROXY)URETHANES FOR ENCAPSULATING PHASE CHANGE MATERIALS AND METHODS OF MAKING THE S Alliance for Energy Innovation, LLC 2024-09-12 US claimed
EP-4696696-A1 IMMOBILIZED QUATERNARY PHOSPHONIUM SALT HAVING PHENOL DOMAIN, METHOD FOR PRODUCING SAME, AND CYCLIC CARBONATE PRODUCTION METHOD USING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-18 EP disclosed
US-20250381557-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-12-18 US disclosed
EP-4545543-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-30 EP disclosed
WO-2024214491-A1 IMMOBILIZED QUATERNARY PHOSPHONIUM SALT HAVING PHENOL DOMAIN, METHOD FOR PRODUCING SAME, AND CYCLIC CARBONATE PRODUCTION METHOD USING SAME 信越化学工業株式会社 2024-10-17 WO disclosed
US-20240301266-A1 POLY(HYDROXY)URETHANES FOR ENCAPSULATING PHASE CHANGE MATERIALS AND METHODS OF MAKING THE S Alliance for Energy Innovation, LLC 2024-09-12 US disclosed
WO-2023248723-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME 信越化学工業株式会社 2023-12-28 WO disclosed
US-20230323031-A1 POLYMER COMPRISING A PLURALITY OF ACTIVE AMINE GROUPS, RELATED POLYMERS AND RELATED METHODS THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-10-12 US disclosed
US-20230323031-A1 POLYMER COMPRISING A PLURALITY OF ACTIVE AMINE GROUPS, RELATED POLYMERS AND RELATED METHODS THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2023-10-12 US disclosed
EP-3994201-B1 SELF-BLOWING ISOCYANATE-FREE POLYURETHANE FOAMS UNIV LIEGE (BE) 2023-09-06 EP disclosed
US-9540537-B2 Coating composition for forming gas barrier layer, gas barrier film, and method for producing gas barrier film DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2017-01-10 US disclosed
US-9540537-B2 Coating composition for forming gas barrier layer, gas barrier film, and method for producing gas barrier film DAINICHISEIKA COLOR & CHEMICALS MFG. CO., LTD. (JP) 2017-01-10 US disclosed
US-20160096921-A1 CAYALYST SYSTEM IND TECH RES INST (TW) 2016-04-07 US disclosed
US-20160096921-A1 CAYALYST SYSTEM IND TECH RES INST (TW) 2016-04-07 US disclosed
US-9260405-B2 Cayalyst system and manufacturing method of cyclic carbonate by the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2016-02-16 US disclosed
US-9260405-B2 Cayalyst system and manufacturing method of cyclic carbonate by the same INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2016-02-16 US disclosed
US-20150183930-A1 FIRE-RESISTANT COMPOSITE MATERIAL IND TECH RES INST (TW) 2015-07-02 US disclosed
EP-2889359-A1 Fire-resistant composite materials and process for preparing thereof Industrial Technology Research Institute (TW) 2015-07-01 EP disclosed
US-20150119584-A1 CAYALYST SYSTEM AND MANUFACTURING METHOD OF CYCLIC CARBONATE BY THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-04-30 US disclosed
US-20150119584-A1 CAYALYST SYSTEM AND MANUFACTURING METHOD OF CYCLIC CARBONATE BY THE SAME INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2015-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250381557-A1 IMMOBILIZED ZINC COMPLEX HAVING GUANIDINE LIGAND, METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING CYCLIC CARBONATE USING SAME CA2, GRIA1, GUCY1A2 TSHR 915/4885ALDH1A1 4014/4885TDP1 3885/4885
US-20230323031-A1 POLYMER COMPRISING A PLURALITY OF ACTIVE AMINE GROUPS, RELATED POLYMERS AND RELATED METHODS THEREOF PARG, PARN, PAM TSHR 4408/4885ALDH1A1 3574/4885TDP1 738/4885
US-20150119584-A1 CAYALYST SYSTEM AND MANUFACTURING METHOD OF CYCLIC CARBONATE BY THE SAME MPST, CA2, CA4 TSHR 2730/4885ALDH1A1 4113/4885TDP1 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.